SEC Form 4 · accession 0001645627-19-000007
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President
Period of report
Feb 25, 2019
Accepted (ET)
Mar 13, 2019 · 4:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 25, 2019 | P | 5,000 | $0.0224 | A | 26,708,897 | D | |
| Common Stock | Mar 1, 2019 | P | 5,000 | $0.0208 | A | 26,713,897 | D | |
| Common Stock | Mar 1, 2019 | P | 1,000 | $0.0218 | A | 26,714,897 | D | |
| Common Stock | Mar 1, 2019 | P | 2,000 | $0.0219 | A | 26,716,897 | D | |
| Common Stock | Feb 25, 2019 | P | 5,000 | $0.0224 | A | 26,721,897 | D | |
| Common Stock | Mar 1, 2019 | P | 2,000 | $0.022 | A | 26,723,897 | D | |
| Common Stock | Mar 6, 2019 | P | 5,000 | $0.0218 | A | 21,728,897 | D | |
| Common Stock | Mar 6, 2019 | P | 5,000 | $0.0207 | A | 21,733,897 | D | |
| Common Stock | Mar 12, 2019 | P | 5,000 | $0.0195 | A | 21,738,897 | D | |
| Common Stock | Mar 12, 2019 | P | 5,000 | $0.0193 | A | 21,743,897 | D | |
| Common Stock | Mar 12, 2019 | P | 1,000 | $0.0188 | A | 21,744,897 | D | |
| Common Stock | Mar 12, 2019 | P | 5,000 | $0.0189 | A | 21,749,897 | D | |
| Common Stock | Mar 12, 2019 | P | 10,000 | $0.0194 | A | 26,759,897 | D |
Table II — derivative securities
No Table II lines on this filing.